Scarica l'app Stockscreener
125.15
0.58%
-0.682
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Abbott Laboratories Borsa (ABT) Ultime notizie
Abbott Laboratories (ABT): I Am Very Upset With Abbott,” Says Jim Cramer - MSN
Top Stock Reports for Wells Fargo, Abbott & American Express - Yahoo Finance
Reckitt Benckiser Group PLC Investors: Please contact the Portnoy Law Firm to recover your losses. August 4, 2025 Deadline to file Lead Plaintiff Motion. - GlobeNewswire Inc.
Brianne Gardner's Top Picks: Abbott Labs, Chipotle Mexican Grill & Motorola Solutions - BNN Bloomberg
Jim Cramer Says He “Was Discouraged to Get a Mixed Update from Abbott Labs” - Insider Monkey
Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know - Yahoo Finance
Declining Stock and Solid Fundamentals: Is The Market Wrong About Abbott Laboratories (NYSE:ABT)? - simplywall.st
Notable healthcare headlines for the week: Trump’s tariff threats, J&J, Abbott Laboratories and Sarepta in focus - MSN
What analysts say about Abbott Laboratories stockPowerful growth strategies - Autocar Professional
Canada Oncology Market Outlook to 2033 - GlobeNewswire Inc.
Abbott Laboratories (NYSE:ABT) Q2 2025 Earnings Call Transcript - MSN
Low-Calorie Food Market Top Companies StudyAbbott - openPR.com
What drives Abbott Laboratories stock priceDynamic portfolio growth - jammulinksnews.com
Estimating The Fair Value Of Abbott Laboratories (NYSE:ABT) - 富途牛牛
Abbott Laboratories: Hold Rating Amid Mixed Performance and Sector Challenges - TipRanks
Abbott Labs stock rating reiterated at Buy by UBS despite guidance cut - Investing.com India
Abbott Laboratories falls after setting Q3 outlook below consensus - MSN
Abbott Laboratories Stock (ABT) Opinions on Q2 Earnings and Guidance Update - Quiver Quantitative
Is Abbott Laboratories (ABT) a Buy After the Earnings Selloff? - AInvest
Abbott Drops After Lowering Top End of Full-Year Guidance - MSN
Abbott Laboratories: A Medtech Titan Positioned for Growth in a Transformed Healthcare Landscape - AInvest
Abbott Laboratories Second Quarter 2025 Earnings: EPS Beats Expectations - Yahoo Finance
Abbott Laboratories Sheds Nearly 5% On A Rare Guidance Miss - MSN
A Quick Look at Today's Ratings for Abbott Laboratories(ABT.US), With a Forecast Between $135 to $159 - 富途牛牛
Analysts Offer Insights on Healthcare Companies: Gain Therapeutics (GANX), Abbott Laboratories (ABT) and ANI Pharmaceuticals (ANIP) - The Globe and Mail
Healthcare Stocks to Watch: Gain Therapeutics, Abbott Laboratories, and ANI Pharmaceuticals - AInvest
How Abbott Laboratories (ABT) Balances Innovation with Shareholder Payouts - MSN
Abbott Laboratories Stock Analysis and ForecastRobust investment performance - jammulinksnews.com
BTIG Remains a Buy on Abbott Laboratories (ABT) - The Globe and Mail
Abbott Laboratories Trading Volume Drops 27.57% to $24.28 Billion Ranking 25th - AInvest
Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield - MSN
Netflix, Abbott Labs Lead Friday’s Market Cap Stock Movers By Investing.com - Investing.com South Africa
Netflix, Abbott Labs Lead Friday’s Market Cap Stock Movers - Investing.com
Abbott Laboratories (NYSE:ABT) Releases Mixed Earnings Report - FXDailyReport.Com
Analysts defend Abbott Labs' stock after Thursday's 'too punitive' sell-off - CNBC
Abbott Laboratories (ABT) Drops on Lower Full-Year Guidance - MSN
Abbott upgraded to Buy at Jefferies despite underwhelming outlook - MSN
Abbott Labs stock price target lowered to $155 at Citi on China diagnostics headwinds - Investing.com UK
1.82%
0.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):